MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression
Derek A. Franklin(Vanderbilt University Medical Center), Justin M. Balko(Vanderbilt University Medical Center)
Cited by 28
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|580
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
|Cancer Immunology Research|2016|493